SmartSyringe
Financiado
SmartSyringe world easiest safest and fastest blood collection ever made.
Blood is the essential physiological parameter when it comes to assess our health, going from routine check-ups to complex
tests for infectious diseases. Each step in the process of the blood draw affects the quality of the specim...
Blood is the essential physiological parameter when it comes to assess our health, going from routine check-ups to complex
tests for infectious diseases. Each step in the process of the blood draw affects the quality of the specimen and is thus
important for preventing laboratory error, patient injury and even death. E.g. the touch of a finger to verify the location of a
vein before insertion of the needle increases the chance that a specimen will be contaminated. This can cause false blood
culture results, prolong hospitalization, delay diagnosis and cause unnecessary use of antibiotics.
A total of 2,947 sharps injuries involving a source patient infected with a blood borne virus were reported by health care
workers, during 2002-2011 in England, Wales and Northern Ireland. Significant sharps injuries were 67% higher in 2011
compared to 2002. Nearly 40% of the injuries occur after use and before the sharp devices are disposed. 41% of the injuries
occur while sharp devices are used and 15% of injuries during disposal or after it.
Every minute, more than 10,000 venipunctures are being performed in the world. However, needles have not changed for
more than 150 years. The needle normally produces only transitory mild discomfort. However, from 3.5 to 10% of the
population suffer from belonephobia (extreme fear of needles) avoiding healthcare settings.
We are developing a needle-free solution which is able to extract, collect and analyse blood in a painless, safe an easy way.
Our approach enables monitoring of major global infectious diseases such as HIV, Malaria and Hepatitis which is key for a
sustainable elimination of such. SmartSyringe represents a breakthrough especially for blood collection in developing
countries. As almost no training is required for proper usage, facilitating diagnostics in areas where there is a lack of
healthcare professionals.
ver más
Duración del proyecto: 4 meses
Fecha Inicio: 2018-05-15
Fecha Fin: 2018-09-30
Fecha Fin: 2018-09-30
Línea de financiación: concedida
El organismo H2020 notifico la concesión del proyecto el día 2018-09-30
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
EIC-SMEInst-2018-2020:
SME instrument
Cerrada
hace 6 años
Presupuesto
El presupuesto total del proyecto asciende a
71K€
Líder del proyecto
swiss aeropole SA
No se ha especificado una descripción o un objeto social para esta compañía.
367.35K€ |
Participante